Tag: paclitazel

1. In patients with advanced, platinum-resistant ovarian cancer, combination therapy of a tyrosine kinase inhibitor, pazopanib, with paclitaxel significantly increased progression-free survival compared to paclitaxel alone. 2. Patients who received pazopanib plus paclitaxel suffered from higher rates of serious side effects including neutropenia, leucopenia, and hypertension. Evidence Rating Level: 2 (Good) Study...